$255.46+4.88% · 3M
Moving avg
1W+4.61%
1M-3.68%
3M+4.88%
6M+15.34%
YTD+19.77%
1Y+30.35%
3Y+177.04%
5Y+111.95%
52-week range
$175.1975% of range$282.15
Company health
Value0/6
Growth3/6
Profitability2/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Revenue compounding 43% a year
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$15.87B
Enterprise value
$13.49B
P/E ratio (TTM)
25.88x
P/S ratio (TTM)
15.17x
EV/EBITDA
1090.37x
Per share & returns
EPS (TTM)
$8.21
Dividend yield
0.00%
Beta (1Y)
0.36
30-day change
-3.68%
Trading
Volume (24h)
408.34K
Previous close
$254.57
Shares outstanding
62.11M
About Ascendis Pharma A/S
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
ASND
Ascendis Pharma A/S is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ under the ticker ASND.
Frequently asked questions
What is Ascendis Pharma A/S's market cap?
Ascendis Pharma A/S (ASND) has a market capitalization of $15.87B.
What is Ascendis Pharma A/S's P/E ratio?
Ascendis Pharma A/S trades at a price-to-earnings (P/E) ratio of 25.88.
What exchange does ASND trade on?
ASND trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.12B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap